232 related articles for article (PubMed ID: 23503685)
1. Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice.
Alajaji M; Bowers MS; Knackstedt L; Damaj MI
Psychopharmacology (Berl); 2013 Aug; 228(3):419-26. PubMed ID: 23503685
[TBL] [Abstract][Full Text] [Related]
2. Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone.
Niedzielska-Andres E; Mizera J; Sadakierska-Chudy A; Pomierny-Chamioło L; Filip M
Behav Brain Res; 2019 Sep; 370():111945. PubMed ID: 31100299
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm.
Abulseoud OA; Miller JD; Wu J; Choi DS; Holschneider DP
Brain Res; 2012 May; 1456():14-21. PubMed ID: 22521042
[TBL] [Abstract][Full Text] [Related]
4. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
Bagdas D; Muldoon PP; Zhu AZ; Tyndale RF; Damaj MI
Neuropharmacology; 2014 Oct; 85():67-72. PubMed ID: 24859605
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression.
LaCrosse AL; Hill K; Knackstedt LA
Eur Neuropsychopharmacol; 2016 Feb; 26(2):186-194. PubMed ID: 26706696
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
Bowers MS; Jackson A; Maldoon PP; Damaj MI
Psychopharmacology (Berl); 2016 Mar; 233(6):995-1003. PubMed ID: 26676982
[TBL] [Abstract][Full Text] [Related]
7. Nucleus accumbens GLT-1a overexpression reduces glutamate efflux during reinstatement of cocaine-seeking but is not sufficient to attenuate reinstatement.
Logan CN; LaCrosse AL; Knackstedt LA
Neuropharmacology; 2018 Jun; 135():297-307. PubMed ID: 29567092
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.
Hammad AM; Alasmari F; Althobaiti YS; Sari Y
Behav Brain Res; 2017 Aug; 332():288-298. PubMed ID: 28624317
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
Ignatowska-Jankowska BM; Muldoon PP; Lichtman AH; Damaj MI
Psychopharmacology (Berl); 2013 Oct; 229(4):591-601. PubMed ID: 23652588
[TBL] [Abstract][Full Text] [Related]
10. The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
Jackson AB; Toma W; Contreras KM; Alkhlaif Y; Damaj MI
Pharmacol Biochem Behav; 2019 Aug; 183():1-5. PubMed ID: 31145916
[TBL] [Abstract][Full Text] [Related]
11. The endogenous cannabinoid system modulates nicotine reward and dependence.
Merritt LL; Martin BR; Walters C; Lichtman AH; Damaj MI
J Pharmacol Exp Ther; 2008 Aug; 326(2):483-92. PubMed ID: 18451315
[TBL] [Abstract][Full Text] [Related]
12. Emergence of dormant conditioned incentive approach by conditioned withdrawal in nicotine addiction.
Scott D; Hiroi N
Biol Psychiatry; 2010 Oct; 68(8):726-32. PubMed ID: 20598291
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation.
Rawls SM; Zielinski M; Patel H; Sacavage S; Baron DA; Patel D
Drug Alcohol Depend; 2010 Mar; 107(2-3):261-3. PubMed ID: 20004063
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking.
Sondheimer I; Knackstedt LA
Behav Brain Res; 2011 Nov; 225(1):252-8. PubMed ID: 21824497
[TBL] [Abstract][Full Text] [Related]
15. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
Pipkin JA; Cruz B; Flores RJ; Hinojosa CA; Carcoba LM; Ibarra M; Francis W; Nazarian A; O'Dell LE
Psychopharmacology (Berl); 2017 May; 234(9-10):1615-1622. PubMed ID: 28342091
[TBL] [Abstract][Full Text] [Related]
16. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Rawls SM; Cavallo F; Capasso A; Ding Z; Raffa RB
Eur J Pharmacol; 2008 Apr; 584(2-3):278-84. PubMed ID: 18342307
[TBL] [Abstract][Full Text] [Related]
17. The histidine triad nucleotide binding 1 protein is involved in nicotine reward and physical nicotine withdrawal in mice.
Jackson KJ; Wang JB; Barbier E; Damaj MI; Chen X
Neurosci Lett; 2013 Aug; 550():129-33. PubMed ID: 23810802
[TBL] [Abstract][Full Text] [Related]
18. The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice.
Chen Z; He Y; Wang ZJ
Neurosci Lett; 2012 Feb; 509(2):69-71. PubMed ID: 22212402
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
Gregg RA; Hicks C; Nayak SU; Tallarida CS; Nucero P; Smith GR; Reitz AB; Rawls SM
Neuropharmacology; 2016 Sep; 108():111-9. PubMed ID: 27085607
[TBL] [Abstract][Full Text] [Related]
20. Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior.
Fischer KD; Houston AC; Rebec GV
J Neurosci; 2013 May; 33(22):9319-27. PubMed ID: 23719800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
